A company still losing money with growing sales. Institutions are adding.
Going well
Sales up 23% in the latest quarter vs a year ago
Sales up 12% last year
Little debt
Watch out for
Losing money
Share count growing 5.7% a year
Money moves
Insiders sold $185K in the last 30 days, all through pre-planned sales
Institutions added 4.3% to their holdings in the quarter ending June 2026 (198 bought, 124 sold)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$38.06+0.4% that day
Company value
$1.4B
Share price times all shares
Price vs sales
1.4x
No profit over the last year, so this compares value with sales instead
Cash vs value
18%
Cash as a share of company value
Debt vs value
9%
Debt as a share of company value
From ICHR's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26
$294.8M+23% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $1.0B, up 9.1% from the 12 months before. Over 5 years, sales grew about 0.7% a year.
What the price assumes
Your guesses, our math
Move the sliders to your own view of ICHR. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
Sales in 5 years$1.6B
Profit in 5 years$156M
Price these guesses point to$46.68+23% vs $38.06 todayAbout +4.2% a year, before dividends
What today's price needs: with a 10% margin and a 15x P/E, sales would have to grow about 4.6% a year for 5 years just to match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.